Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions
Our partner Felipe Mesquita and attorney at law Carolina Mendes had their article “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” published this Thursday (August 4), by the "Kluwer Patent Blog" website. It addresses recent decisions in litigation involving pharma patents that honor the protection of industrial property rights despite the public health challenges faced in Brazil. Full article at: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/
-
Felipe Mesquita sócio e Carolina Mendes, advogada, tiveram seu artigo “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” publicado hoje (4/8), no site "Kluwer Patent Blog". O artigo aborda recentes decisões em litígios envolvendo patentes farmacêuticas que prestigiam a proteção aos direitos de propriedade industrial apesar dos desafios de saúde pública enfrentados no Brasil. Leia o texto na íntegra: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/
Co-Authored by:
RECENT PUBLICATIONS
-
Behind Brazil's "Unbeaten Record" in SEP Litigation: Licks Attorneys' Shenzhen Strategy
April 13, 2026 -
O Direito à compensação in natura em razão da mora administrativa injustificada: Abordagem da responsabilidade civil estatal na condução dos processos administrativos de concessão de patentes
April 09, 2026 -
Compulsory Licensing in Brazil (2026): The Mounjaro Case
April 06, 2026